Filtered By:
Management: Funding
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 11357 results found since Jan 2013.
Cardiva Medical wins expanded FDA indications for Vascade vascular closure system
Cardiva Medical said today it won expanded indications from the FDA for its Vascade vascular closure system, now cleared for use in 5-7F femoral venous closures in addition to arterial closure.
The Vascade system is composed of a thrombogenic bioabsorbable collagen patch and a collapsible mesh disc, the Santa Clara, Calif.-based company said.
The device functions by placing a collapsible mesh disc against the inner vessel wall to stop bleeding followed by a collagen patch and the removal of the mesh disc, the company said. The collagen patch is designed to expand, seal and stop bleeding and is later absorbed by the body....
Source: Mass Device - April 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Vascular Cardiva Medical Inc. Source Type: news
Vascular Therapies raises $12m for drug-eluting vascular access implant
Vascular Therapies has raised $12.4 million from 29 investors as part of a $21.1 million round, according to a document filed last week with the SEC.
The Cresskill, N.J.-based company is developing a sirolimus-eluting collagen implant for patients with end-stage renal disease. The bioresorbable drug-delivery system is designed to keep open a portal of entry into a patient’s vascular system for hemodialysis.
Get the full story at our sister site, Drug Delivery Business News.
The post Vascular Therapies raises $12m for drug-eluting vascular access implant appeared first on MassDevice.
Source: Mass Device - October 15, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Featured Funding Roundup Pharmaceuticals Vascular vasculartherapies Source Type: news
Comparison of Academic Productivity and Funding Support Between American and International Medical Graduate Vascular Surgeons
The demand for vascular surgeons stands to far exceed the current supply. International medical graduates (IMGs) are not only vital to meeting the country ’s growing health care needs, but help to advance clinical research and medical education. Nearly 17% of vascular surgeons in the United States are IMGs, yet little is known about their relative contributions to academic vascular surgery. Our study aims to compare the academic profiles and funding support for IMG vascular surgeons to that of their American medical graduate (AMG) counterparts.
Source: Journal of Vascular Surgery - May 19, 2022 Category: Surgery Authors: Khaled I. Alnahhal, Ranjana Lingutla, Suhas Penukonda, Ali Irshad, Payam Salehi Tags: IP: Interactive Poster Session Source Type: research
NIH Funding Among Vascular Surgeons Is Rare and Aligns Poorly With Society for Vascular Surgery Priorities
The National Institutes of Health (NIH) is an essential source of funding for vascular surgeon-scientists. NIH funding is frequently used to benchmark institutional and individual research productivity, help determine eligibility for academic promotion, and as a measure of scientific quality. We sought to determine NIH-funded vascular surgeon characteristics along with amounts, types, and content areas of NIH funding. In addition, we also sought to determine whether funded grants addressed recent Society for Vascular Surgery (SVS) research priorities.
Source: Journal of Vascular Surgery - December 21, 2022 Category: Surgery Authors: Amin A. Mirzaie, Michol A. Cooper, Christopher R. Jacobs, Morgan L. Cox, Scott A. Berceli, Salvatore T. Scali, Thomas S. Huber, Martin R. Back, Gilbert R. Upchurch, Samir K. Shah Source Type: research
Comparison of Academic Productivity and Funding Support between United States and International Medical Graduate Vascular Surgeons
The demand for vascular surgeons in the United States (US) stands to far exceed the current supply. International Medical Graduates (IMGs) are not only vital to meeting the country ’s growing healthcare needs, but also help to advance clinical research and medical education in the field of vascular surgery. Nearly 17% of practicing vascular surgeons in the U.S. are IMGs, yet little is known about their relative contributions to academic vascular surgery. Our study aims to co mpare the academic profiles and funding support for IMG vascular surgeons to that of their US medical graduate (USMG) counterparts.
Source: Journal of Vascular Surgery - January 2, 2023 Category: Surgery Authors: Khaled I. Alnahhal, Ranjana Lingutla, Suhas Penukonda, Ali Irshad, Shivani Kumar, Bernadette Aulivola, Payam Salehi Source Type: research
Enhancing the vascular surgeon-scientist workforce with diversity and team science
In this issue of the Journal of Vascular Surgery, Mirzaie et al1 show that, in 2022, only 1% of vascular surgeons receive National Institutes of Health (NIH) funding, with female surgeons representing 37% of funded surgeons. They also show that NIH-funded projects covered only seven of 10 Society for Vascular Surgery (SVS) research priorities. These data ar e consistent with prior analyses showing that vascular surgeons received a small proportion (4.2%) of NIH funding to surgeon-scientists, and this rate has not changed since 1995 (4.6% of grant funding in 1995 to 4.2% in 2020); more generally, less than 2% of NIH inves...
Source: Journal of Vascular Surgery - September 20, 2023 Category: Surgery Authors: Mytien Nguyen, Alan Dardik Tags: Invited Commentary Source Type: research
Pulsar Vascular raises $9.5m for PulseRider aneurysm device
Pulsar Vascular, which makes the PulseRider device for treating brain aneurysms, said it raised nearly $9.5 million from 39 unnamed investors.
The 1st sale in the equity, debt and options round happened July 27, San Jose, Calif.-based Pulsar Vascular said in a regulatory filing.
The PulseRider device is designed to shore up the blood vessels around wide-necked aneurysms at or near a bifurcation of the basilar tip or carotid terminus and facilitate the implantation of an embolization coil, without obstructing blood flow through the vessels, according to the company’s website.
The device, which won CE Mark approval ...
Source: Mass Device - September 11, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Neurological Pulsar Vascular Source Type: news
Velano Vascular raises $17m for needle-free blood draw device
Velano Vascular said today that it raised $17 million from new and existing investors for its Pivo needle-free blood draw device.
The San Francisco, Calif.-based company said its Pivo device is a single-use disposable product designed to collect blood from indwelling peripheral IV lines, reducing the need for needle sticks and central line access for blood collection.
Velano Vascular plans to use the funding to scale and commercialize a family of vascular access technologies, including the Pivo device.
“This level of investment is a tremendous validation of our team’s effort to establish a true, more compass...
Source: Mass Device - March 7, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Blood Management Funding Roundup Wall Street Beat Velano Vascular Source Type: news
Vascular access device maker Stent Tek closes Series A
Medical device firm Stent Tek said today it closed an undisclosed Series A financing round to support the development of its ePath AVF minimally invasive catheter technology.
The ePath AVF device is designed for vascular access as an alternative to surgical fistulas for hemodialysis patients.
Money in the round came from institutional investors Julz and Deepbridge Capital, the London-based company said.
Stent Tek has previously received $1.6 million (GBP £1.2 million) in grant funding from the National Institute of Health Research, Innovate UK and the Royal Academy of Engineering Enterprise Hub.
“I was thoroughly im...
Source: Mass Device - August 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Stents Vascular stenttek Source Type: news
Singapore vascular access dev Advent Access raises $2m in pre-Series A
Singapore-based vascular access dev Advent Access has raised $1.9 million (SGD $2.6 million) in a pre-Series A financing round to support its av-Guardian technology designed to create vascular access for dialysis patients.
The funding round was led by Accuron MedTech, which the company touted as the largest medical device company in southeast Asia. The investment went through Singapore’s Spring Seeds Capital-assigned accelerator the Med Tech Alliance, Advent Access said.
“We are excited to lead the pre-Series A investment in Advent Access given the company’s strong progress and potential to transform and ...
Source: Mass Device - December 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Vascular adventaccess Source Type: news
Cardiva Medical adds $11m for vascular closure devices
Cardiva Medical said yesterday that it added another $11 million to a funding round it closed last year at $30 million to continue the commercialization of its Vascade vascular closure device.
Existing debt and equity investors participated, including PTV Healthcare Capital, Canepa Healthcare and affiliates of Luther King Capital Mgmt., the Santa Clara, Calif.-based company said.
In March 2017 Cardiva said it had put a bow around the $30 million round for Vascade, which won 510(k) clearance from the FDA in February 2013. Yesterday the company said the latest infusion will also go toward its Ambulate investigational devic...
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Vascular Wall Street Beat Cardiva Medical Inc. Source Type: news
National Institutes of Health funding among vascular surgeons is rare
The National Institutes of Health (NIH) is an essential source of funding for vascular surgeons conducting research. NIH funding is frequently used to benchmark institutional and individual research productivity, help determine eligibility for academic promotion, and as a measure of scientific quality. We sought to appraise the current scope of NIH funding to vascular surgeons by appraising the characteristics of NIH-funded investigators and projects. In addition, we also sought to determine whether funded grants addressed recent Society for Vascular Surgery (SVS) research priorities.
Source: Journal of Vascular Surgery - June 14, 2023 Category: Surgery Authors: Amin A. Mirzaie, Michol A. Cooper, M. Libby Weaver, Christopher R. Jacobs, Morgan L. Cox, Scott A. Berceli, Salvatore T. Scali, Martin R. Back, Thomas S. Huber, Gilbert R. Upchurch, Samir K. Shah Source Type: research
Velano Vascular draws $3.5m funding round
Velano Vascular said today that it raised another $3.5 million for its needle-free blood draw device.
San Francisco-based Velano said it plans to use the proceeds from the round to further develop and commercialize the device.
Prior backers First Round Capital, White Owl Capital, Kapor Capital, Safeguard Scientifics, Griffin Hospital, The Children’s Hospital of Philadelphia and “a number of health industry veterans” joined the round, the company said. New investors included ex-Becton Dickinson (NYSE:BDX) chairman & CEO Ed Ludwig, “individual members of the Medline leadership team,” Osc...
Source: Mass Device - February 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Hospital Care Velano Vascular Source Type: news
Boston Scientific gets in on $45m private placement for Corindus Vascular Robotics
Boston Scientific (NYSE:BSX) got in on a $45 million private placement for Corindus Vascular Robotics (NYSE:CVRS) and the CorPath GRX device it’s developing for cardiac and peripheral vascular procedures.
New investors BioStar Ventures, Consonance Capital and Hudson Executive Capital also participated, joining existing backers HealthCor Partners Management and Royal Philips (NYSE:PHG).
“We are pleased to announce this financing and appreciate the support of our new and existing investors,” president & CEO Mark Toland said in prepared remarks. “The additional capital will allow us to conti...
Source: Mass Device - February 28, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Robot-Assisted Surgery Wall Street Beat Boston Scientific Corindus Vascular Robotics Royal Philips Source Type: news
Access Vascular raises $3m for anti-clot PICC technology
Access Vascular raised more than $3 million from a consortium of new and existing investors that CEO Jim Biggins said should be sufficient to carry the company through a post-market clinical evaluation of its HyrdoPICC catheter and into the regulatory process for its next iteration.
Biggins told MassDevice.com yesterday that the $3.4 million round was led by a “family office in the Boston area” that’s backed Access since its 2015 inception.
“They’ve been supporting us since the beginning of the company and they helped price and lead this most recent round,” he told us, adding that half...
Source: Mass Device - August 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Catheters Funding Roundup Vascular Wall Street Beat accessvascular Source Type: news
